The score is constrained primarily by weak financial performance, driven by steep revenue contraction, large ongoing losses, and a highly concerning balance sheet with negative equity. Technical indicators also reflect bearish trend conditions, with only limited near-term relief suggested by oversold oscillators. Valuation is unattractive due to losses (negative P/E) and no indicated dividend yield support.
Positive Factors
High gross profit margin
A gross margin near 52% indicates the company’s core services generate healthy unit economics. That level of underlying margin provides structural capacity to absorb SG&A and support recovery in operating profits if revenue stabilizes or fixed costs are restructured over the medium term.
Positive operating cash flow
Generating positive operating cash flow despite accounting losses shows the business can convert some service activity into cash. This durable cash generation reduces immediate liquidity pressure, supports operational continuity, and gives management runway to implement restructuring or efficiency measures.
Healthcare services industry exposure
Being positioned in medical care facilities exposes the company to structural demand for health services. This industry alignment provides a defensive revenue base and long-term relevance, supporting potential demand resilience as management addresses operational and financial shortcomings.
Negative Factors
Steep revenue contraction
A 30% year-over-year revenue drop is structurally damaging: it reduces scale economics and gross profit dollars, strains fixed-cost coverage, and can erode market position. Reversing such a decline is essential for sustainable recovery and requires durable demand or successful business repositioning.
Large ongoing losses
A net margin near -63% reflects substantial recurring losses that deplete capital and hinder reinvestment. Persisting operating deficits weaken ability to self-fund turnaround initiatives, increase reliance on external financing, and raise the risk of prolonged impairment to shareholder value.
Weak balance sheet and negative equity
Negative shareholders' equity and an inverted debt-to-equity signal acute balance-sheet stress. This structural weakness limits access to traditional financing, increases refinancing and solvency risk, and may force dilutive capital raises or restructuring that materially constrain strategic options.
Good Fellow Healthcare Holdings Limited (8143) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$131.89M
Dividend YieldN/A
Average Volume (3M)491.55K
Price to Earnings (P/E)―
Beta (1Y)-0.22
Revenue Growth-30.45%
EPS Growth-734.38%
CountryHK
Employees118
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,127,299,900
10 Day Avg. Volume447,466
30 Day Avg. Volume491,551
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)-8.05
Price to Sales (P/S)3.25
P/FCF Ratio20.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model
Company DescriptionGood Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.
How the Company Makes Moneynull
Good Fellow Healthcare Holdings Limited Financial Statement Overview
Summary
Overall fundamentals are weak: revenue declined sharply (-30.73%) and profitability is deeply negative (net margin -62.82%) with negative EBIT/EBITDA margins. The balance sheet is a major concern with negative shareholders’ equity and high leverage dependence. Operating cash flow is positive, but free cash flow growth is very negative (-116.36%) and cash generation is limited versus losses.
Income Statement
30
Negative
The company has experienced a significant decline in revenue, with a revenue growth rate of -30.73% in the most recent year. Gross profit margin is relatively stable at 51.92%, but the net profit margin is deeply negative at -62.82%, indicating substantial losses. EBIT and EBITDA margins are also negative, reflecting operational challenges.
Balance Sheet
20
Very Negative
The balance sheet shows a concerning negative stockholders' equity, leading to a negative debt-to-equity ratio of -1.62. Return on equity is alarmingly high at 155.58%, driven by negative equity, indicating financial instability. The equity ratio is negative, suggesting the company is heavily reliant on debt financing.
Cash Flow
40
Negative
The company has managed to generate positive operating cash flow, but free cash flow growth is negative at -116.36%. The operating cash flow to net income ratio is low at 0.16, and free cash flow to net income ratio is close to 1, indicating limited cash flow generation relative to net losses.
Breakdown
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2021
Income Statement
Total Revenue
16.12M
38.96M
55.35M
54.24M
53.89M
Gross Profit
8.37M
18.67M
27.01M
26.66M
26.45M
EBITDA
1.86M
-10.12M
1.83M
4.38M
-23.55M
Net Income
-10.13M
-17.11M
-5.88M
-12.69M
-30.18M
Balance Sheet
Total Assets
9.83M
29.15M
41.70M
60.45M
191.38M
Cash, Cash Equivalents and Short-Term Investments
4.14M
3.88M
18.36M
25.15M
44.89M
Total Debt
10.53M
12.23M
4.49M
7.36M
29.73M
Total Liabilities
16.59M
27.74M
22.32M
34.08M
158.48M
Stockholders Equity
-6.51M
4.36M
22.19M
29.59M
40.23M
Cash Flow
Free Cash Flow
2.58M
-15.35M
-3.84M
-24.51M
-21.21M
Operating Cash Flow
2.62M
-854.00K
-1.32M
-22.93M
1.25M
Investing Cash Flow
-1.57M
-14.46M
5.74M
2.19M
-24.28M
Financing Cash Flow
1.06M
4.36M
-2.75M
-5.61M
4.83M
Good Fellow Healthcare Holdings Limited Technical Analysis
Technical Analysis Sentiment
Negative
Last Price0.19
Price Trends
50DMA
0.14
Negative
100DMA
0.16
Negative
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
47.34
Neutral
STOCH
62.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Negative. The current price of 0.19 is above the 20-day moving average (MA) of 0.11, above the 50-day MA of 0.14, and above the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.34 is Neutral, neither overbought nor oversold. The STOCH value of 62.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8143.
Good Fellow Healthcare Holdings Limited Peers Comparison
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026